Introduction of Pro and Its Analogues in the Conserved P1 Position of Trypsin Inhibitor SFTI-1 Retains Its Inhibitory Activity
作者:Anna Legowska、Dawid Debowski、Rafal Lukajtis、Emilia Sztabkowska、Aneta Mizeria、Krzysztof Brzozowski、Magdalena Wysocka、Adam Lesner、Krzysztof Rolka
DOI:10.2174/092986611797201002
日期:2011.11.1
A number of monocyclic SFTI-1 analogues modified in the conserved inhibitor P1 position by Pro, its L-hydroxyproline (Hyp) derivative as well as mimetics with different ring size were synthesized by the solid-phase method. Replacement of Ser6 by Pro, Hyp, and a four-member ring, L-azetidine-2-carboxylic acid (Aze), retained trypsin or chymotrypsin inhibitory activity. The determined association equilibrium constants of these analogues with a cognate enzyme were about two orders of magnitude lower than those obtained for ones with conserved Ser6. In all analogues, with the exception of one, [Phe5,Aze6]SFTI-1, the P1-P1 reactive site remained intact. The results provide first evidence that the conserved Ser in the P1 position of Bowman-Birk inhibitors can be successfully replaced by an amino acid with a secondary amine group.
通过固相法合成了许多单环SFTI-1类似物,在保守的抑制剂P1位上分别用脯氨酸、其L-羟脯氨酸(Hyp)衍生物以及具有不同环大小的模拟物进行了修饰。用脯氨酸、Hyp和四元环L-氮杂环丁烷-2-羧酸(Aze)取代Ser6保留了胰蛋白酶或糜蛋白酶的抑制活性。这些类似物与同源酶的确定的结合平衡常数比保守的Ser6的常数低两个数量级。在所有类似物中,除了一种[Phe5,Aze6]SFTI-1外,P1-P1反应位点保持不变。这些结果首次证明,鲍曼-比尔克抑制剂P1位上保守的Ser可以成功地被具有仲胺基团的氨基酸取代。